Related Experiment Videos
Comparison between GDx VCC parameter and achromatic perimetry in glaucoma patients.
Michele Iester1, Andrea Perdicchi, Fabio De Feo
1Department of Neurological Sciences, Ophthalmology, Genetic, Clinica Oculistica, University of Genoa, Genoa, Italy. iester@unige.it
Journal of Glaucoma
|July 26, 2006
Summary
This study found that the nerve fiber indicator (NFI) from GDx VCC is the best predictor of visual field damage in glaucoma patients, correlating significantly with standard perimetry indices.
Area of Science:
- Ophthalmology
- Medical Imaging
- Glaucoma Research
Background:
- Glaucoma is a leading cause of irreversible blindness.
- Accurate assessment of visual field damage is crucial for glaucoma management.
- Optical coherence tomography (OCT) and perimetry are standard diagnostic tools.
Purpose of the Study:
- To evaluate the correlation between polarimetry parameters obtained via GDx variable corneal compensator (VCC) and standard threshold perimetry indices.
- To identify which GDx VCC parameter best predicts visual field damage in glaucoma patients.
Main Methods:
- 108 glaucomatous patients underwent GDx VCC imaging and Humphrey visual field testing (24-2 SITA standard).
- Correlation coefficients were calculated between GDx VCC parameters and visual field indices (Mean Deviation, Pattern Standard Deviation).
- A linear regression model identified the most predictive GDx VCC parameter for visual field damage.
Main Results:
- Significant correlations were observed between Mean Deviation (MD) and GDx VCC parameters, notably the nerve fiber indicator (NFI) (r=-0.35).
- Significant correlations were also found between Pattern Standard Deviation (PSD) and NFI (r=0.39).
- Linear regression analysis identified NFI as the primary predictor variable for both MD and PSD.
Conclusions:
- Certain GDx VCC indices correlate significantly with visual field indices in glaucoma.
- The nerve fiber indicator (NFI) emerged as the most effective indicator of visual field damage in this cohort.
- GDx VCC, particularly NFI, shows promise as a tool for monitoring glaucoma progression.